Gestão do programa de monitorização contínua de glicose com as mulheres atendidas na Secretaria de Saúde do Distrito Federal

Abstract

Introduction: Diabetes Mellitus is a multifactorial metabolic disease characterized by hyperglycemia. Increasingly prevalent in the global population, evidence suggests that women are particularly affected by the disease. It is necessary to consider the biosociopsychocultural context to understand and optimize their adherence to available treatments. The Health Department of the Federal District implemented the Glucose Monitoring Program aimed at distributing sensors to users with Type 1 Diabetes Mellitus. Objective: Develop an instrument that facilitates understanding of the information necessary for access and participation in the Continuous Glucose Monitoring Program of the Health Department of the Federal District. Methods: This study is aligned with the research line of Quality in Women's Health Care of the Stricto Sensu Postgraduate Program in Health Sciences. Methodological study with a quantitative approach, conducted in two phases. The first involved an observational, retrospective analytical study with women participating in the program. In the second stage, a tool for program management improvement was developed. The study took place at the Specialized Center for Diabetes, Obesity, and Arterial Hypertension. Data collection was based on spreadsheets generated from responses to electronic forms, collected from December 2020 to December 2021. Results were analyzed descriptively, for association, and through multiple logistic regression. The project was approved by the Research Ethics Committee, approval protocol 5,475,356. RESULTS: 109 women participated, married (45.88%), with a completed higher education (85.19%), monthly family income over U$1,000 (69.33%), and without children (55.84%). They self-reported as white (61.47%), without acute complications (hypoglycemia) or chronic complications of the disease (retinopathy, neuropathy, and diabetic nephropathy). Glycated hemoglobin was evaluated at the beginning and end of the program using the non-parametric Wilcoxon test. Patients who remained in the program had significantly lower initial glycated hemoglobin values than those who left the program. Multiple binary logistic regression identified key explanatory variables associated with program outcomes. For each additional year of age, the likelihood of remaining in the program increased by 1.104 times. The duration of Type 1 Diabetes diagnosis was negatively associated with the outcome, indicating an inversely proportional relationship. Education, duration of diagnosis, and glycated hemoglobin are important factors for women's participation in the program. Conclusion: The program is a public initiative that aligns with the global trend of distributing technological products to improve the management of impactful diseases. The distribution of glucose sensors to Type 1 Diabetes Mellitus patients by the Health Department is a global trend-aligned initiative that may contribute to reducing acute and chronic complications faced by the female population. Products: Products developed: Produced an article with a study design in the methodological research. With analysis in this study, aspects related to the health technology used in the care of people with diabetes mellitus were identified. The technology produced is the Patient Manual of the SES/DF Continuous Monitoring Program, with 28 pages, contains answers to the main questions presented by users about the dynamics of the request process, updating the website of the Health Department where there is relevant information for the public. The access link: https://drive.google.com/file/d/1QNtUExOSdMoze5AVbKYkgFTbMtUxVD4T/view?usp=drivesdk .